NO20082395L - Krystallinske former av 1'-(1-metyl)-4'-[(2-fluor-4-metoksyfenyl)metyl]-5'-metyl-1H-pyrazol-3'-O-beta-D-glucopyranosid, en fremstillingsmetode og anvendelse av denne for fremstilling av medikamenter - Google Patents
Krystallinske former av 1'-(1-metyl)-4'-[(2-fluor-4-metoksyfenyl)metyl]-5'-metyl-1H-pyrazol-3'-O-beta-D-glucopyranosid, en fremstillingsmetode og anvendelse av denne for fremstilling av medikamenterInfo
- Publication number
- NO20082395L NO20082395L NO20082395A NO20082395A NO20082395L NO 20082395 L NO20082395 L NO 20082395L NO 20082395 A NO20082395 A NO 20082395A NO 20082395 A NO20082395 A NO 20082395A NO 20082395 L NO20082395 L NO 20082395L
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- manufacture
- glucopyranoside
- pyrazole
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Oppfinnelsen angår en krystallinsk form av 1´-(1-metyletyl)-4´-[(2-fluor-4-metoksyfenyl)metyl]-5´-metyl-1H-pyrazol-3´-O-ß-D-glukopyranosid, en metode for fremstilling av denne, så vel som anvendelsen av denne for fremstilling av medikamenter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06000483 | 2006-01-11 | ||
PCT/EP2007/050209 WO2007080170A1 (en) | 2006-01-11 | 2007-01-10 | CRYSTALLINE FORM OF 1´-(1-METHYLETHYL)- 4´-[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5´-METHYL-1H-PYRAZOL-3´-O-β-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082395L true NO20082395L (no) | 2008-07-31 |
Family
ID=35953998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082395A NO20082395L (no) | 2006-01-11 | 2008-05-27 | Krystallinske former av 1'-(1-metyl)-4'-[(2-fluor-4-metoksyfenyl)metyl]-5'-metyl-1H-pyrazol-3'-O-beta-D-glucopyranosid, en fremstillingsmetode og anvendelse av denne for fremstilling av medikamenter |
Country Status (19)
Country | Link |
---|---|
US (2) | US7524822B2 (no) |
EP (1) | EP1976859A1 (no) |
JP (1) | JP4936234B2 (no) |
KR (1) | KR20090012205A (no) |
CN (1) | CN101370816A (no) |
AR (1) | AR058962A1 (no) |
AU (1) | AU2007204368A1 (no) |
BR (1) | BRPI0706375A2 (no) |
CA (1) | CA2635203A1 (no) |
EA (1) | EA200801663A1 (no) |
EC (1) | ECSP088501A (no) |
IL (1) | IL192655A0 (no) |
NO (1) | NO20082395L (no) |
NZ (1) | NZ570311A (no) |
PE (1) | PE20071237A1 (no) |
TW (1) | TW200745149A (no) |
UY (1) | UY30082A1 (no) |
WO (1) | WO2007080170A1 (no) |
ZA (1) | ZA200804151B (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4530855B2 (ja) * | 2002-10-04 | 2010-08-25 | キッセイ薬品工業株式会社 | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
AU2008344436B2 (en) * | 2007-12-27 | 2013-08-29 | Kissei Pharmaceutical Co., Ltd. | Monosebacate of pyrazole derivative |
CN102007138B (zh) * | 2008-04-16 | 2014-05-21 | 橘生药品工业株式会社 | 吡唑衍生物的半富马酸盐 |
UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
CA2771278A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
KR101019079B1 (ko) * | 2010-12-28 | 2011-03-07 | 최점미 | 돌침대용 온열 제어장치 |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP4245765A3 (en) | 2013-04-04 | 2024-03-20 | Boehringer Ingelheim Vetmedica GmbH | Treatment of metabolic disorders in equine animals |
CN105828815B (zh) | 2013-12-17 | 2020-03-27 | 勃林格殷格翰动物保健有限公司 | 猫科动物中代谢紊乱的治疗 |
PL3485890T3 (pl) * | 2014-01-23 | 2023-08-28 | Boehringer Ingelheim Vetmedica Gmbh | Inhibitory SGLT2 do leczenia zaburzeń metabolicznych u zwierząt psowatych |
EP3112350B1 (en) * | 2014-02-28 | 2018-04-04 | Sumitomo Chemical Company, Limited | Method for producing pyrazole compound |
DK3125882T3 (da) | 2014-04-01 | 2020-06-29 | Boehringer Ingelheim Vetmedica Gmbh | Behandling af metabolske lidelser i hestedyr |
EP3197429A1 (en) | 2014-09-25 | 2017-08-02 | Boehringer Ingelheim Vetmedica GmbH | Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals |
CN105061322B (zh) * | 2015-07-27 | 2018-07-24 | 北京颖泰嘉和生物科技股份有限公司 | N-取代的3-羟基吡唑化合物的制备方法 |
US10220017B2 (en) | 2015-08-27 | 2019-03-05 | Boehringer Ingelheim Vetmedica Gmbh | Liquid pharmaceutical compositions comprising SGLT-2 inhibitors |
US20230381101A1 (en) | 2022-05-25 | 2023-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Aqueous pharmaceutical compositions comprising sglt-2 inhibitors |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE264337T1 (de) | 1999-08-31 | 2004-04-15 | Kissei Pharmaceutical | Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung |
AU2002210990A1 (en) * | 2000-11-02 | 2002-05-15 | Ajinomoto Co. Inc. | Novel pyrazole derivatives and diabetes remedies containing the same |
PL209375B1 (pl) | 2000-12-28 | 2011-08-31 | Kissei Pharmaceutical | Pochodne glukopiranozyloksypirazolu, kompozycja farmaceutyczna zawierająca takie pochodne i zastosowanie tych pochodnych do wytwarzania kompozycji farmaceutycznej |
EP1364957B1 (en) | 2001-02-26 | 2008-12-31 | Kissei Pharmaceutical Co., Ltd. | Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
WO2002083857A2 (en) | 2001-04-10 | 2002-10-24 | Millennium Pharmaceuticals, Inc. | 68723, sodium/glucose cotransporter family members and uses therefor |
EP1389621A4 (en) | 2001-04-27 | 2005-05-11 | Ajinomoto Kk | N-SUBSTITUTED PYRAZOLYL-O-GLYCOSIDE DERIVATIVES AND DIABETES CONTAINING THEREOF |
CA2448741C (en) | 2001-05-30 | 2010-06-22 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
JP4115105B2 (ja) | 2001-07-02 | 2008-07-09 | 協和醗酵工業株式会社 | ピラゾール誘導体 |
WO2003020737A1 (en) | 2001-09-05 | 2003-03-13 | Bristol-Myers Squibb Company | O-pyrazole glucoside sglt2 inhibitors and method of use |
US7956041B2 (en) | 2002-04-26 | 2011-06-07 | Ajinomoto Co., Inc. | Prophylactic and therapeutic agent of diabetes mellitus |
WO2003090783A1 (fr) | 2002-04-26 | 2003-11-06 | Ajinomoto Co., Inc. | Agent preventif/remede pour diabete |
ITBO20020050U1 (it) | 2002-05-13 | 2003-11-13 | Netpack S R L | Contenitore per prodotti ortofrutticoli |
AU2003254847B2 (en) | 2002-08-08 | 2009-06-04 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
AU2003262262A1 (en) | 2002-08-27 | 2004-03-19 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
JP4530855B2 (ja) | 2002-10-04 | 2010-08-25 | キッセイ薬品工業株式会社 | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
US20060035844A1 (en) | 2002-12-04 | 2006-02-16 | Fumiaki Ito | Preventive or remedy for diseases caused by hyperglycemia |
WO2004089967A1 (ja) | 2003-04-01 | 2004-10-21 | Taisho Pharmaceutical Co., Ltd. | ヘテロアリール 5-チオ-β-D-グルコピラノシド誘導体及びそれを含有する糖尿病治療薬 |
US7439232B2 (en) | 2003-04-01 | 2008-10-21 | Taisho Pharmaceutical Co., Ltd. | Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same |
EP1637539B1 (en) | 2003-06-20 | 2012-01-18 | Kissei Pharmaceutical Co., Ltd. | Pyrazole derivative, drug composition containing the same and production intermediate therefor |
CA2539032A1 (en) | 2003-08-26 | 2005-03-10 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-pirazoles, drugs containing said compounds the use and production method thereof |
US7375090B2 (en) | 2003-08-26 | 2008-05-20 | Boehringer Ingelheim International Gmbh | Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof |
MX2008000011A (es) | 2005-07-22 | 2008-03-26 | Boehringer Ingelheim Int | Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos. |
UY29694A1 (es) | 2005-07-28 | 2007-02-28 | Boehringer Ingelheim Int | Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
US20080020987A1 (en) | 2006-07-20 | 2008-01-24 | Waldemar Pfrengle | Processes for preparing pyrazole-O-glycoside derivatives and novel intermediates of said processes |
-
2007
- 2007-01-05 UY UY30082A patent/UY30082A1/es not_active Application Discontinuation
- 2007-01-09 PE PE2007000017A patent/PE20071237A1/es not_active Application Discontinuation
- 2007-01-10 CA CA002635203A patent/CA2635203A1/en not_active Abandoned
- 2007-01-10 AR ARP070100090A patent/AR058962A1/es unknown
- 2007-01-10 WO PCT/EP2007/050209 patent/WO2007080170A1/en active Application Filing
- 2007-01-10 AU AU2007204368A patent/AU2007204368A1/en not_active Abandoned
- 2007-01-10 US US11/621,859 patent/US7524822B2/en not_active Expired - Fee Related
- 2007-01-10 BR BRPI0706375-0A patent/BRPI0706375A2/pt not_active IP Right Cessation
- 2007-01-10 CN CNA2007800030344A patent/CN101370816A/zh active Pending
- 2007-01-10 KR KR1020087019563A patent/KR20090012205A/ko not_active Application Discontinuation
- 2007-01-10 JP JP2008549026A patent/JP4936234B2/ja not_active Expired - Fee Related
- 2007-01-10 EA EA200801663A patent/EA200801663A1/ru unknown
- 2007-01-10 EP EP07703756A patent/EP1976859A1/en not_active Withdrawn
- 2007-01-10 NZ NZ570311A patent/NZ570311A/en unknown
- 2007-01-10 TW TW096100941A patent/TW200745149A/zh unknown
-
2008
- 2008-05-14 ZA ZA200804151A patent/ZA200804151B/xx unknown
- 2008-05-27 NO NO20082395A patent/NO20082395L/no not_active Application Discontinuation
- 2008-06-04 EC EC2008008501A patent/ECSP088501A/es unknown
- 2008-07-07 IL IL192655A patent/IL192655A0/en unknown
-
2009
- 2009-03-16 US US12/404,442 patent/US7838500B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EA200801663A1 (ru) | 2009-02-27 |
EP1976859A1 (en) | 2008-10-08 |
KR20090012205A (ko) | 2009-02-02 |
NZ570311A (en) | 2010-05-28 |
PE20071237A1 (es) | 2008-01-15 |
JP4936234B2 (ja) | 2012-05-23 |
TW200745149A (en) | 2007-12-16 |
ZA200804151B (en) | 2009-10-28 |
AR058962A1 (es) | 2008-03-05 |
US20090181905A1 (en) | 2009-07-16 |
UY30082A1 (es) | 2007-08-31 |
US7524822B2 (en) | 2009-04-28 |
ECSP088501A (es) | 2008-07-30 |
CA2635203A1 (en) | 2007-07-19 |
IL192655A0 (en) | 2009-02-11 |
US7838500B2 (en) | 2010-11-23 |
CN101370816A (zh) | 2009-02-18 |
AU2007204368A1 (en) | 2007-07-19 |
JP2009522340A (ja) | 2009-06-11 |
US20070244176A1 (en) | 2007-10-18 |
BRPI0706375A2 (pt) | 2011-03-22 |
WO2007080170A1 (en) | 2007-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082395L (no) | Krystallinske former av 1'-(1-metyl)-4'-[(2-fluor-4-metoksyfenyl)metyl]-5'-metyl-1H-pyrazol-3'-O-beta-D-glucopyranosid, en fremstillingsmetode og anvendelse av denne for fremstilling av medikamenter | |
WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
NO20073875L (no) | Krystallformer av 1-klor-4-(B-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloksy)-benzyl]-benzen, metode for fremstilling samt anvendelse for fremstilling av medikamenter | |
NO20065946L (no) | DPP-IV-inhibitorer | |
DK1881967T3 (da) | Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika | |
ZA200804079B (en) | Parthenogenic activation of human oocytes for the production of human embroyonic stem cells | |
NO20091133L (no) | Anvendelse av 2-6-(3-amino-piperidin-L-yl)-3-metyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmetyl-4-fluor-benzonitril | |
NO20083669L (no) | 4-aryl-2amino-pyrimidiner eller 4-aryl-2-aminoalkylpyrimidiner som jak-2-modulatorer og fremgangsmater for anvendelse derav | |
NO345139B1 (no) | Florizinanaloger som inhibitorer av glukosekotransportør 2 og farmasøytisk sammensetning derav | |
WO2008009415A3 (de) | 4-heteroaryl-substituierte 1-aminocyclohexan-1- und cyclohexen-1-derivate mit wirkung auf das opiod rezeptor system | |
DK3421471T3 (da) | Purin- og deazapurinderivater som farmaceutiske forbindelser | |
MY148429A (en) | Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof | |
DK2049557T3 (da) | 1-(-D-glycopyranosyl)-3-(4-cyclopropylphenylmethyl)-4-halogenindolderivater og anvendelse heraf som sglt-inhibitorer | |
DK2074122T5 (da) | Pyrido (2, 3-d) pyrimidin0n-forbindelser og anvendelse deraf som pi3 inhibitorer | |
EA200900282A1 (ru) | Применение полиолов для получения устойчивых полиморфных форм рифаксимина | |
NO20091509L (no) | Substituerte tetrahydropyrrolopyrazinforbindelser med affinitet KCNQ2/3 K+ kanal og anvendelse derav i medikamenter | |
DK3133070T3 (da) | Eliglustat (genz 112638) som inhibitor af glucosylceramidsyntase til anvendelse i en fremgangsmåde til behandling af fabrys eller gauchers sygdom, hvilken fremgangsmåde omfatter justering af den individuelle terapeutiske dosis i forhold til patientens p-450-metabolisme | |
NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
MY151973A (en) | Cyclic depsipeptides | |
WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
DK1994005T3 (da) | Tetrahydronaphthalinderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelseshæmmere | |
WO2007099171A3 (en) | Bicyclo-pyrazoles active as kinase inhibitors | |
DE602007012313D1 (de) | Als a2b-adenosinrezeptorantagonisten geeignete 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4,5-büpyridin-2-onderivate | |
WO2008073863A3 (en) | Preparation and utility of substituted allylamines | |
WO2006105482A3 (en) | Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |